基因决定的代谢物对流行的泌尿癌易感性的因果关系:一个双样本的门德尔随机化研究和元分析
Xianyu Dai1, Hongjie Wang1, Rong Zhong1
1Urology Department, First Hospital of Jilin University, Changchun, China.
Frontiers in genetics
|July 16, 2024
概括
这项研究使用了门德尔的随机化来发现血液代谢物和泌尿癌之间的联系. 它确定了脏,前列腺,膀和丸癌的潜在生物标志物和治疗点.
科学领域:
- 代谢学和癌症研究
- 遗传流行病学遗传流行病学
- 泌尿外科瘤学 泌尿外科瘤学
背景情况:
- 泌尿系统癌症 (脏,前列腺,膀,丸) 是全球主要的健康问题.
- 代谢学通过研究小分子提供了对癌症发展的见解.
- 关于代谢物与癌症的因果关系存在一个知识差距.
研究的目的:
- 研究遗传决定性代谢物与对四种常见泌尿癌的易感性之间的因果关系.
- 确定尿道恶性瘤的潜在生物标志物和治疗点.
- 解决了解泌尿道癌症病因学的现有差距.
主要方法:
- 使用全基因组关联研究 (GWAS) 数据进行双样本孟德尔随机化 (MR) 分析.
- 作为主要的MR方法,逆方差加权 (IVW),加权中位数 (WM) 进行校正.
- 强度检查包括MR-Egger,MR-PRESSO和元分析.
主要成果:
- 分析了645种代谢物,在初步的MR中揭示了96种潜在的因果关系.
- 分析确定了68种与尿道癌相关的血液代谢物.
- 在前列腺癌和高水平的4-基甲尼尔之间发现了显著的因果关系.
结论:
- 这项MR研究阐明了血液代谢物和泌尿癌之间的因果关系.
- 已识别的代谢物可以作为新的生物标志物和治疗点.
- 这些发现为尿道癌症研究中的有针对性的干预提供了基础.
相关概念视频
Mutagenicity and Carcinogenicity
1.2K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.2K
Cancer Prevention
6.1K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.1K
Mismatch Repair
40.0K
Overview
40.0K
Mutations
81.6K
Overview
81.6K
Cancers Originate from Somatic Mutations in a Single Cell
11.9K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
11.9K
Genome-wide Association Studies-GWAS
13.3K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
13.3K


